Annual report pursuant to Section 13 and 15(d)

Investment in account receivable (Details Narrative)

v3.23.1
Investment in account receivable (Details Narrative) - USD ($)
12 Months Ended
Feb. 15, 2022
Apr. 10, 2015
Dec. 31, 2022
Dec. 31, 2021
Dec. 31, 2020
Jan. 10, 2023
Collaborative Arrangement and Arrangement Other than Collaborative [Line Items]            
Warrants price per share     $ 2.11 $ 2.11    
Warrants redemption price     $ 0.10      
Impairment of investments     $ 22,718 $ (139,148)  
Gain (loss) on investment receivable $ (41,930)   (41,930) (22,718)    
Gain (loss) on investment receivable $ 41,930   41,930 22,718    
Amortization of debt discount     $ 56,806 $ 65,657    
Subsequent Event [Member]            
Collaborative Arrangement and Arrangement Other than Collaborative [Line Items]            
Annual installment payments           $ 117,000
Due in 2023           117,000
Due in 2024           117,000
Due in 2025           $ 117,000
Exchange Agreement [Member]            
Collaborative Arrangement and Arrangement Other than Collaborative [Line Items]            
Account receivable with annual installment payments   $ 117,000        
Annual installment receivable, term   11 years        
Shares issued, value   $ 1,287,000        
Shares issued, shares   757,059        
Investment in account receivable discount percent       17.87%    
Exchange Agreement [Member] | Series D Warrants [Member]            
Collaborative Arrangement and Arrangement Other than Collaborative [Line Items]            
Warrants issued   757,059        
Warrants price per share   $ 1.60        
Warrants redemption price   $ 0.10